Bill

Bill > H4943


MA H4943

MA H4943
Relative to epinephrine injectors


summary

Introduced
01/23/2026
In Committee
01/23/2026
Crossed Over
Passed
Dead

Introduced Session

194th General Court

Bill Summary

Relative to epinephrine injectors

AI Summary

This bill mandates that various health insurance plans and programs in Massachusetts must cover the appropriate weight-based dosage of epinephrine injectors, which are devices approved by the U.S. Food and Drug Administration (FDA) for administering epinephrine, including auto-injectors and pre-filled syringes with pre-measured doses equivalent to auto-injectors. This coverage requirement applies to state employees insured through the Group Insurance Commission, individuals covered by Medicaid-managed care or primary care clinician plans, and those with various types of private insurance policies, including accident and sickness insurance, employers' health and welfare funds, hospital service plans, medical service agreements, and health maintenance contracts. Importantly, these epinephrine injectors cannot be subjected to higher deductibles, coinsurance, copayments, or out-of-pocket limits than other prescribed drugs covered by the respective plans.

Committee Categories

Health and Social Services

Sponsors (0)

No sponsors listed

Other Sponsors (1)

Joint Committee on Financial Services (Joint)

Last Action

Reported favorably by committee and referred to the Joint Committee on Health Care Financing (on 01/23/2026)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Document Type Source Location
State Bill Page https://malegislature.gov/Bills/194/H4943
BillText https://malegislature.gov/Bills/194/H4943.pdf
Loading...